Connect with us

Technology

From Pilot to Production: Axtria and LangChain Partner to Govern and Scale AI Agents in Pharma

Published

on

Axtria’s pharma-native AgentOps framework and LangChain’s leading agent development platform help life sciences enterprises deploy AI agents with confidence and turn experimentation into operational results

BERKELEY HEIGHTS, N.J., April 29, 2026 /PRNewswire/ — Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced a strategic partnership with LangChain,  the company behind the industry-standard LangSmith platform for building, deploying, and observing AI agents at scale. Together, the two organizations will help life sciences enterprises turn agentic AI experiments into operational results in production.

The partnership centers on Axtria’s AgentOps framework, a pharma-native governance layer built on LangSmith, providing enterprise clients with the visibility, compliance controls, and evaluation rigor to responsibly scale AI agents in regulated environments. The framework is already in production at a leading global biopharma delivering measurable gains in agent observability, evaluation quality, and governance compliance and is live across Axtria’s own InsightsMAx.ai multi-agent platform

LangSmith delivers the foundational infrastructure: building deep long-horizon agents, end-to-end agent tracing, prompt management, agent evaluation and deployments tooling. Axtria adds the pharma intelligence layer including Look-Alike, Sound-Alike (LASA) drug safety evaluators to prevent dangerous medication confusions, GxP compliance enforcement, patient safety detection, and persona-driven dashboards for Medical Affairs, Medical Legal Review, Commercial, and IT stakeholders.

What This Means for Life Sciences Organizations

Most pharma and biotech companies have AI agent pilots underway. Few have crossed the threshold into reliable, governed production. Two challenges consistently block the path: regulated environments demand a level of traceability and compliance that generic AI tooling does not provide, and the domain expertise required to define ‘good’ for a medical affairs agent is fundamentally different from a commercial or compliance one. This partnership directly addresses both.

Commercial: Field Agents That Actually Get Used: Pre-call planning agents surface HCP insights and next-best-action recommendations ahead of every rep interaction. The solution tracks not just what the agent recommends but whether reps act on it. Performance is continuously tuned on real field feedback, creating a direct, measurable link between agent output and commercial results.

Medical Affairs: From Query to Defensible Answer: When a Medical Affairs team deploys an oncology agent to answer HCP queries, every response is automatically checked for drug name confusion, validated against approved labeling, and fully traceable. If a regulator asks how the system reached a conclusion, the complete decision path is on record. No retroactive documentation. No manual reconstruction.

Medical Legal Review: Compliance Built In, Not Bolted On: Promotional content is pre-screened against FDA-approved labeling before it ever reaches a human reviewer — claims validated, off-label risks flagged, fair balance checked. The audit trail isn’t assembled after the fact. It’s a byproduct of how the agent works.

“Axtria has spent more than 15 years helping the world’s leading life sciences companies turn data into decisions, and AI agents are the next frontier of that mission. Our clients are past the question of whether agents can work they’re asking how to make them work reliably across the enterprise and tie that performance to real results. This partnership with LangChain gives them exactly that: the governance foundation, the operational playbook, and the agent capabilities to move from experimentation to enterprise scale without starting from scratch,” Navdeep (Navi) Chadha, Co-founder & EVP, Axtria.

“We know what AI agents can do, but the true value for the enterprise is in how reliably, safely, and transparently they do it. Axtria brings exactly the domain depth and operational rigor that life sciences organizations need to move from experimentation to production-grade AI. Together, we’re giving pharma companies a clear path from agent deployment to real, defensible business outcomes,” Karan Singh, Head of Partnerships, LangChain.

What the Partnership Delivers

Together, Axtria and LangChain offer life sciences organizations an integrated, enterprise-ready solution spanning the full agentic AI lifecycle:

Agents as a Service: Pre-built, pharma-validated agents across Commercial, Medical Affairs, Patient Services, and Data Engineering deployable and governed from day one, without building from scratch.Pharma-Native Observability & Governance: Enterprise-grade visibility, compliance enforcement, and audit-readiness built specifically for regulated environments covering GxP traceability, immutable audit trails, and model version tracking.Cost Intelligence: Portfolio-level cost governance that helps enterprises optimize AI spend, right-size model selection, and prevent runaway costs without compromising safety or quality.

Learn More

Life sciences organizations interested in moving their AI agent programs from pilot to production can request a demo at connect@axtria.com.  

About Axtria 

Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. A leading global provider of award-winning cloud software and data analytics, Axtria delivers proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption. For more information, visit www.axtria.com

About LangChain

LangChain is the agent engineering platform powering top engineering teams, from AI startups to global enterprises. Its open-source frameworks, including LangChain, LangGraph, and Deep Agents, have surpassed 1 billion cumulative downloads and are used by over one million practitioners. LangSmith, the observability, evaluation, and deployment platform, serves over 300 enterprise customers and 5 of the Fortune 10. LangChain is backed by Sequoia Capital, Benchmark, and IVP. For more information, visit langchain.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/from-pilot-to-production-axtria-and-langchain-partner-to-govern-and-scale-ai-agents-in-pharma-302757028.html

SOURCE Axtria, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

/C O R R E C T I O N — MDA Space/

Published

on

By

In the news release, MDA Space announces definitive agreement to acquire US-based Blue Canyon Technologies LLC, issued 19-Jun-2026 by MDA Space over PR Newswire, we are advised by the company that a change has been made. The complete, corrected release follows:

MDA Space announces definitive agreement to acquire US-based Blue Canyon Technologies LLC

Expands Total Addressable Market for MDA SpacePositions company to further pursue substantial US defence market opportunitiesAdds a profitable, cash-generating business with 18-year historyTransaction expected to be accretive to Adjusted EBITDA1 and Adjusted EPS1 in 2027Adds high-quality spacecraft and satellite component supplier business and US$3.5B (approx. C$4.9B) to pipelineComplementary technology and customer setAdds key talent & manufacturing facilities in Denver, Colorado space & aerospace hub

TORONTO, June 19, 2026 /PRNewswire/ – MDA Space Ltd. (TSX:MDA) (NYSE:MDA) (the “Company”), a trusted mission partner to the rapidly expanding global space industry, has signed a definitive agreement to acquire 100% of the membership interests of Blue Canyon Technologies LLC in an all-cash transaction for a purchase price and enterprise value of US$620 million (approximately C$874 million), subject to purchase price adjustments. Blue Canyon Technologies (BCT) is a spacecraft and satellite component manufacturer and mission services provider, currently part of RTX’s Raytheon business.

With more than 85 spacecraft launched and 3,500+ products on orbit, BCT has established impressive flight heritage and mission success since the company was founded in 2008. Once completed, the transaction is expected to provide MDA Space with a strategic business and manufacturing footprint to capitalize on growing demand in the US government market for defence space missions. With over 400 highly skilled employees and two manufacturing facilities in the Denver, Colorado space and aerospace hub, BCT offers a diverse and innovative product portfolio that enables a broad range of missions for the space economy.

“The acquisition of Blue Canyon Technologies is expected to accelerate our growth strategy by increasing our US market opportunities with highly complementary capabilities, local manufacturing footprint and a skilled and specialized talent base,” said Mike Greenley, CEO of MDA Space. “Securing those strategic benefits on an accretive basis with a profitable and cash-generating business makes this an ideal fit for MDA Space expansion and continued shareholder value creation.” 

Transaction Details

The transaction will add a profitable, cash-generating business that is expected to be accretive to Adjusted EBITDA and Adjusted EPS in 2027. With an 18-year history, BCT is a high-quality spacecraft and satellite component supplier that will add US$3.5B (approximately C$4.9B) to our opportunity pipeline. The transaction is expected to close by the end of 2026, subject to customary closing conditions and required regulatory approvals, and is fully committed and financed at signing through senior secured debt. As part of our ongoing capital allocation framework, we will evaluate opportunities to optimize our capital structure over time, subject to market conditions and broader capital deployment priorities. This transaction is expected to result in 2026 pro forma leverage within our stated target range of 1.5x to 2.5x net debt to last twelve months adjusted EBITDA. 

Conference Call

MDA Space will host a conference call and webcast to discuss the transaction on Friday, June 19, 2026 at 8:30 a.m. ET. Interested parties can join the call by dialing 1-416-945-7677 (Toronto area) or 1-888-699-1199 (toll-free North America) or +44-800-279-7040 (toll-free United Kingdom) and entering the conference ID 30111. A live webcast of the conference call and an accompanying slide presentation will be available at https://mda-en.investorroom.com/events-presentations.

A replay of the webcast will be archived on the MDA Space Investor Relations website following the call. Parties may also access a recording of the call, which will be available until June 26, 2026, by dialing 1-888-660-6345 and entering the passcode 30111#.

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects the company’s current expectations regarding future events. Such forward-looking information includes, but is not limited to, information with respect to the Company’s objectives and strategies to achieve these objectives, as well as information with respect to the Company’s beliefs, plans, expectations, anticipations, estimates, intentions and views of future events, including statements regarding the proposed acquisition, the anticipated timing for the closing of the acquisition, the anticipated benefits, synergies and growth opportunities expected to result from the acquisition, and any projected, estimated or forecasted financial information presented in connection therewith. There can be no assurance that: (i) the acquisition will be completed on the anticipated timeline, or at all, and the closing of the acquisition may be delayed or may not occur within the anticipated timeframe or at all; (ii) the conditions to the closing of the acquisition will be satisfied, including the receipt of all required regulatory, governmental and third-party approvals, and the failure to obtain any such approvals or satisfy any such conditions could delay or prevent the closing of the acquisition; (iii) any projected, estimated or forecasted financial information presented in connection with the acquisition will be achieved, as such projections are based on assumptions that may prove to be incorrect, and actual results may differ materially from those projected, estimated or forecasted; and (iv) the anticipated strategic benefits, growth opportunities and synergies described in connection with the acquisition will be realized as expected, or at all, as such benefits may take longer to realize than anticipated, may be more costly to achieve than expected, or may not be realized at all.

All forward-looking statements are based on assumptions and analyses made by MDA Space in light of management’s experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties and other factors which may cause the actual results, performance or achievements of MDA Space to differ materially from those anticipated in such forward-looking statements for a variety of reasons, including without limitation the risk that the acquisition will not be completed on the anticipated timeline or at all, the risk that conditions to the closing of the acquisition will not be satisfied, including the receipt of all required regulatory, governmental and third-party approvals, and the risks and uncertainties detailed under the “Risk Factors” section of MDA Space’s annual information form dated March 4, 2026. Although MDA Space believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect and there can be no assurance that actual results will be consistent with the forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements or information included within this press release. These forward-looking statements speak only as of the date of this news release. Except as required by law, MDA Space is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

ABOUT MDA SPACE
Building the space between proven and possible, MDA Space (TSX:MDA) (NYSE:MDA) is a trusted mission partner to the global defence and space industry. A robotics, satellite systems and geointelligence pioneer with a 55-year+ story of world firsts and more than 450 missions, MDA Space is a global leader in communications satellites, Earth and space observation, and space exploration and infrastructure. The global MDA Space team of more than 4,000 space experts has the knowledge and know-how to turn an audacious customer vision into an achievable mission — bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that’s been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we’ll take you there. For more information, visit mda.space.

SOCIAL MEDIA
LinkedIn: LinkedIn.com/company/MDAspace
X: X.com/MDA_space
Facebook: Facebook.com/MDAspace
YouTube: YouTube.com/c/MDAspace
Instagram: instagram.com/MDA_space

1 Non-IFRS measure

Correction: The MDA logo has been exchanged for the MDA Space logo.

View original content to download multimedia:https://www.prnewswire.com/news-releases/mda-space-announces-definitive-agreement-to-acquire-us-based-blue-canyon-technologies-llc-302805322.html

SOURCE MDA Space

Continue Reading

Technology

BSE Index Services launches BSE Saatvik 100 Index

Published

on

By

MUMBAI, India, June 19, 2026 /PRNewswire/ — BSE Index Services Pvt. Ltd., a wholly owned subsidiary of BSE, today announced the launch of India’s 1st Saatvik Index, BSE Saatvik 100. The Index is derived from the constituents of BSE 500 Index that align with Saatvik principles.

The BSE Saatvik 100 Index has a base value of 1000, first value date is 20th June 2005, and it is reconstituted Semi-annually in June & December.

Speaking at the launch, Mr. Ashutosh Singh, MD & CEO, BSE Index Services Pvt. Ltd. said, “The launch of the BSE Saatvik 100 Index marks an important step in broadening the range of thematic indices available to investors seeking alignment between their investment decisions and value-based principles. As capital markets continue to evolve, investor preferences are increasingly extending beyond traditional financial metrics to include ethical, cultural and philosophy-driven considerations. The Index represents a distinctive addition to India’s indexing landscape and provides market participants with a credible foundation for the development of passive, structured and other investment products aligned with this philosophy.”

This new index can be used for running passive strategies such as ETFs and Index Funds. It can also be used for benchmarking of PMS strategies, MF schemes and fund portfolio. Investors can now access a broader spectrum of market opportunities, further enriching their investment strategies with this latest addition to BSE’s suite of indices.

Click here to know more about the index.

About BSE INDEX SERVICES PRIVATE LIMITED:

BSE Index Services Pvt. Ltd. (formerly Asia Index Pvt. Ltd.) is a wholly owned subsidiary of BSE Ltd, Asia’s oldest stock exchange and home to the iconic SENSEX index – a leading indicator of Indian equity market performance. BSE Index Services Pvt. Ltd aims to provide a full array of indices to global / domestic investors and calculates, publishes, and maintains a diverse family of indices.

About BSE:

BSE is Asia’s oldest exchange and the world’s largest exchange in terms of the number of listed companies. BSE has been playing a prominent role in developing the Indian capital market and has successfully offered an efficient capital raising platform to many companies in India. The benchmark index of BSE, Sensex, is tracked by investors across the globe is also considered as a barometer for the growth of Indian Economy. BSE provides an efficient and transparent market for trading in equity, debt instruments, equity derivatives, currency derivatives, interest rate derivatives, mutual funds, stock lending and borrowing.

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/bse-index-services-launches-bse-saatvik-100-index-302805321.html

Continue Reading

Technology

Belgravia Hartford Provides Technical Progress Update on gravitio.ai it’s Prediction Intelligence Platform

Published

on

By

Gravitio reports 5,874 recorded AI-agent predictions since April 2026, more than 8,000 cloned AI agents, early internal crypto and football prediction-performance metrics, expanded sports coverage, and continued development of its proprietary prediction-performance data layer.

TORONTO, June 19, 2026 /PRNewswire/ – Belgravia Hartford Capital Inc. (CSE: BLGV) (OTCQB: BLGVF) (FRA: ECA) (“Belgravia” or the “Company”) is pleased to provide a technical progress update for https://gravitio.ai (“Gravitio”), the Company’s fully wholly owned AI-powered prediction intelligence platform.

Gravitio has advanced its AI-agent infrastructure, prediction-tracking systems, scoring formulas, sports coverage, and market-signal tools, generating 5,874 recorded AI-agent predictions and expanding to more than 8,000 cloned AI agents across supported categories. These developments strengthen Gravitio’s ability to analyze selected market and event data, generate structured predictions, evaluate outcomes, and build a proprietary prediction-performance data layer.

Internal Prediction Performance

Gravitio’s crypto-market agents have recorded approximately 65% accuracy across selected short-term and long-term crypto prediction categories, based on the internal tracking methodology and completed predictions measured through Gravitio’s internal result-tracking process. For World Cup 2026-related football activity, Gravitio is tracking approximately 60% live accuracy across early tournament data, including match outcomes, scoring, and tournament-related categories.

These internal performance metrics are based on Company records and internal methodology. They have not been independently validated and should be viewed as product-development indicators only, not as guarantees of future prediction accuracy, trading performance, betting results, user outcomes, revenue, or commercial success. Such predictions are not financial advice or recommendations to place any wager or expect financial returns. Past predictions do not guarantee or reflect future outcomes.

User Growth Since Pilot Stage

Since Gravitio began pilot-stage activity in April 2026, the platform has grown to more than 4,000 registered users, primarily through web-based channels, early online discovery, and initial user onboarding. Belgravia views this early registered user base as an initial indicator of interest in Gravitio’s AI-agent, prediction, challenge, and gamification features as the platform advances through its public market rollout.

AI-Agent Infrastructure and Proprietary Data Layer

Gravitio’s AI-agent architecture supports scalable testing across various markets, sports categories, time horizons, prediction models, and data-weighting structures. Beyond generating predictions, this infrastructure underpins a proprietary prediction-performance data layer: every AI-agent prediction, user prediction, confidence score, scoring event, and verified outcome can contribute structured data that may support stronger AI models, agent benchmarking, user-performance scoring, improved rankings, advanced analytics, and potential business-to-business intelligence applications.

Sports, Scoring, and Market-Signal Improvements

Gravitio has expanded its sports prediction coverage beyond FIFA 2026 Tournament to include LALIGA, SERIEA, BUNDESLIGA, LIGUE1, MLS, UCL, MLB, UFC, F1, EUROLEAGUE, NBA, AFL. Gravitio has also improved its tournament prediction and scoring framework, including updated formulas that place greater weight on higher-precision predictions and category-specific difficulty, to better evaluate prediction quality and create more useful performance data across sports and event categories. Gravitio continues to improve its data-gathering and market-signal infrastructure to support stronger data ingestion, better event tracking, and more consistent evaluation of prediction results.

Market and Jurisdictional Expansion

Belgravia is reviewing opportunities to introduce Gravitio across additional markets and jurisdictions as part of its broader growth plan, considering regulatory requirements, product availability, user demand, sports and financial-data access, technology infrastructure, third-party data dependencies, payment systems, app-store availability, and local compliance considerations.

CTO Commentary

Mr.Mehrdad Safarmohammadloo, Chief Technology Officer of Gravitio, commented:

“Since April, our focus has been on strengthening the technical foundation of Gravitio. We have expanded our AI-agent infrastructure, increased the number of recorded predictions, improved our data pipelines, and developed new scoring formulas to better evaluate prediction performance across different categories. The most important part of this work is the data layer behind the system — every agent prediction, user prediction, final result, and scoring event helps us understand how the platform performs and where it can improve. Gravitio is being designed as an adaptive prediction system, not a static prediction application. Our objective is to continue improving the relationship between data, AI agents, human prediction activity, and verified outcomes as we prepare the platform for broader commercial, market, and jurisdictional expansion.”

About Gravitio

Gravitio is an AI-powered prediction intelligence platform developed by Belgravia Hartford Capital Inc., designed to analyze selected markets, sports, events, and real-world outcomes through AI agents, data gathering, machine-learning systems, user predictions, scoring formulas, and performance tracking. Gravitio is publicly available through its web, iOS, and Android applications. For more information, visit https://gravitio.ai.

About Belgravia Hartford Capital Inc.

Belgravia Hartford Capital Inc. is an investment issuer focused on technology, finance, artificial intelligence, digital assets, and related investment opportunities. Listed for trading on the Canadian Securities Exchange and OTCQB, focused on the tech and finance sectors of the Bitcoin ecosystem. The Company’s focus, as set out in its 2018 Investment Policy, specifies cryptocurrencies, artificial intelligence, media and digital streaming opportunities. Belgravia invests in a portfolio of private and public companies located in jurisdictions governed by the rule of law. Belgravia and its investments are considered very high-risk holdings, and it may expose shareholders to significant volatility and losses.

Forward-Looking Statements and Disclaimer

This press release contains forward-looking statements regarding Belgravia, Gravitio, the Company’s technology development strategy, AI-agent infrastructure, prediction systems, sports prediction features, World Cup 2026-related prediction activity, user growth, scoring systems, data infrastructure, third-party validation options, market and jurisdictional expansion, product development, and future commercial opportunities. Forward-looking statements are based on current expectations and are subject to risks, uncertainties, regulatory requirements, technical dependencies, product validation, market conditions, commercial execution risk, digital asset market volatility, user adoption, data availability, third-party service dependencies, app-store requirements, payment-processing requirements, and other factors that may cause actual results to differ materially.

Gravitio’s prediction outputs are probabilistic and are not guaranteed. Any references to prediction accuracy, verified predictions, agent performance, scoring systems, user counts, or internal tracking results are based on Company records and internal methodology and may change as additional data becomes available. The internal prediction-performance metrics described in this press release have not been independently validated and should not be interpreted as a guarantee of future prediction accuracy, investment performance, trading performance, betting results, user outcomes, revenue, or commercial success.

The content of this press release should not be interpreted as financial advice, investment advice, trading advice, betting and gambling advice, or a guarantee of profit, income, prediction accuracy, or future monetary return.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/belgravia-hartford-provides-technical-progress-update-on-gravitioai-its-prediction-intelligence-platform-302805214.html

SOURCE Belgravia Hartford Capital Inc.

Continue Reading

Trending